GB201210328D0 - Biomarker - Google Patents

Biomarker

Info

Publication number
GB201210328D0
GB201210328D0 GB201210328A GB201210328A GB201210328D0 GB 201210328 D0 GB201210328 D0 GB 201210328D0 GB 201210328 A GB201210328 A GB 201210328A GB 201210328 A GB201210328 A GB 201210328A GB 201210328 D0 GB201210328 D0 GB 201210328D0
Authority
GB
United Kingdom
Prior art keywords
patient
methods
relates
tnf
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201210328A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GB201210328A priority Critical patent/GB201210328D0/en
Publication of GB201210328D0 publication Critical patent/GB201210328D0/en
Priority to PCT/GB2013/051518 priority patent/WO2013186541A1/fr
Ceased legal-status Critical Current

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
GB201210328A 2012-06-12 2012-06-12 Biomarker Ceased GB201210328D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201210328A GB201210328D0 (en) 2012-06-12 2012-06-12 Biomarker
PCT/GB2013/051518 WO2013186541A1 (fr) 2012-06-12 2013-06-10 Biomarqueur pour la détermination de la compatibilité d'une thérapie anti-facteur de nécrose tumorale (anti-tnf) dans le traitement de maladies auto-immunes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201210328A GB201210328D0 (en) 2012-06-12 2012-06-12 Biomarker

Publications (1)

Publication Number Publication Date
GB201210328D0 true GB201210328D0 (en) 2012-07-25

Family

ID=46605772

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201210328A Ceased GB201210328D0 (en) 2012-06-12 2012-06-12 Biomarker

Country Status (2)

Country Link
GB (1) GB201210328D0 (fr)
WO (1) WO2013186541A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072340A2 (fr) * 2004-01-27 2005-08-11 Compugen Ltd. Nouveaux polynucleotides codant pour des polypeptides et leurs procedes d'utilisation
US7785834B2 (en) * 2005-11-10 2010-08-31 Ercole Biotech, Inc. Soluble TNF receptors and their use in treatment of disease
AU2007272824B2 (en) * 2006-07-13 2013-08-01 Life Technologies Corporation Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
WO2008093323A2 (fr) * 2007-01-29 2008-08-07 Compugen Ltd. Nucléotide et séquences d'acides aminés atypiques, et leurs procédés d'utilisation dans un diagnostic

Also Published As

Publication number Publication date
WO2013186541A1 (fr) 2013-12-19

Similar Documents

Publication Publication Date Title
TN2013000412A1 (en) Bcma-based stratification and therapy for multiple myeloma patients
MX2022006075A (es) Antagonistas de union a pd-l1 y usos de los mismos para el tratamiento de cancer.
MX2013008833A (es) Metodos y composiciones relacionadas con la inhibicion de receptor del factor de crecimiento similar a la insulina 1 (igf-1r).
MX2022015821A (es) Nuevos receptores de celulas t y usos de los mismos.
NZ722055A (en) Fcrn antagonists and methods of use
JO3242B1 (ar) طرق علاج داء السكري بمستضادات dll4
PH12016501406A1 (en) Interleukin-2-fusion proteins and uses thereof
EA201391789A1 (ru) TNF-АЛЬФА АНТИГЕНСВЯЗЫВАЮЩИЕ БЕЛКИ, ОБЛАДАЮЩИЕ ПОВЫШЕННЫМ СВЯЗЫВАНИЕМ FcRn
MX2015016814A (es) Anticuerpo anti-tweakr y sus usos.
PH12017500331A1 (en) Antigen binding proteins that bind cxcr5
GB201021289D0 (en) Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
MX353143B (es) Marcadores biologicos y metodos para pronosticar respuesta a antagonistas de celulas b.
MX347972B (es) Anticuerpos estables y solubles que inhiben el vegf.
MX2011012039A (es) Anticuerpos bloqueadores anti-dkk-1 y sus usos.
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
EA201791984A1 (ru) Способы уменьшения уровня fc-содержащих агентов в сыворотке с применением fcrn-антагонистов
NZ604415A (en) Anti-il-23 heterodimer specific antibodies
EA201590187A1 (ru) Моноклональные антитела для применения в диагностике и терапии злокачественных опухолей и аутоиммунного заболевания
CL2012002081A1 (es) Anticuerpo humanizado que se une a la cadena alfa del receptor de il-7 humano (cd127); proteina de enlace a antigeno que comprende una o mas regiones determinantes de complementariedad de dicho anticuerpo; molecula de acido nucleico que codifica una anticuerpo o proteina de enalce; vector de expresion, celula huesped recombinante; procedimiento para la produccion de una proteina de enlace a antigeno; procedimiento para tratar enfermedad autoinmune o inflamatoria.
EA201400964A1 (ru) Cx3cr1-связывающие полипептиды
EA201690503A1 (ru) Антитела
MX2017004742A (es) Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos.
MX2020010094A (es) Kir3dl3 como receptor de hhla2, anticuerpos anti-hhla2 y usos de estos.
MA39847A (fr) Protéines de liaison à l'antigène se liant à wisp1
PH12017500332A1 (en) Antigen binding proteins that bind cxcr3

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)